Larval debridement therapy: an economic, scientific and clinical evaluation

Share this article

Larval debridement therapy: an economic, scientific and clinical evaluation

1 January 2013

Larval therapy, also known as maggot therapy or biosurgery, has a long history of use in the treatment of chronic and infected wounds. This supplement includes an evaluation on the cost-effectiveness of LDT, the science of LDT and how to set up a LDT service in today’s changing NHS.

Supported by BioMonde.

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.